WEREWOLF THERAPEUTICS, INC. Cash and Cash Equivalents
WEREWOLF THERAPEUTICS, INC. (HOWL) had Cash and Cash Equivalents of $21.99 million as of 2026-06-30, per its S-4 filed 2026-09-22.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-09-22
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $21.99M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $46.45M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $57.05M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $65.71M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $21.99M S-4 · filed 2026-09-22 |
| 2026-03-31 | $46.45M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $57.05M S-4 · filed 2026-09-22 |
| 2025-09-30 | $65.71M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $77.60M S-4 · filed 2026-09-22 |
| 2025-03-31 | $92.04M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $111.00M S-4 · filed 2026-09-22 |
| 2024-09-30 | $122.83M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $135.30M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $139.19M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $134.34M 10-K · filed 2025-03-11 |
| 2023-09-30 | $130.06M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $137.45M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $147.87M 10-Q · filed 2024-05-03 |
| 2022-12-31 | $129.31M 10-K · filed 2024-03-07 |
| 2022-09-30 | $140.45M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $145.71M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $143.71M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $157.53M 10-Q · filed 2023-11-14 |
| 2021-09-30 | $170.44M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $183.23M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $84.60M 10-Q · filed 2021-06-10 |
| 2020-12-31 | $92.57M 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |